BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ariff B, Lloyd CR, Khan S, Shariff M, Thillainayagam AV, Bansi DS, Khan SA, Taylor-Robinson SD, Lim AK. Imaging of liver cancer. World J Gastroenterol 2009; 15(11): 1289-1300 [PMID: 19294758 DOI: 10.3748/wjg.15.1289] [Cited by in CrossRef: 71] [Cited by in F6Publishing: 50] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Loss M, Jung E, Scherer M, Farkas S, Schlitt H. Chirurgische Therapie von Lebermetastasen. Chirurg 2010;81:533-41. [DOI: 10.1007/s00104-010-1891-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
2 Sitthichai S, Pilapong C, Thongtem T, Thongtem S. CMC-coated Fe 3 O 4 nanoparticles as new MRI probes for hepatocellular carcinoma. Applied Surface Science 2015;356:972-7. [DOI: 10.1016/j.apsusc.2015.08.140] [Cited by in Crossref: 53] [Cited by in F6Publishing: 33] [Article Influence: 7.6] [Reference Citation Analysis]
3 Malla RR, Kumari S, Kgk D, Momin S, Nagaraju GP. Nanotheranostics: Their role in hepatocellular carcinoma. Critical Reviews in Oncology/Hematology 2020;151:102968. [DOI: 10.1016/j.critrevonc.2020.102968] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
4 Jakab Z. [Diagnostic imaging for the screening of hepatocellular carcinoma]. Orv Hetil 2010;151:1083-90. [PMID: 20558357 DOI: 10.1556/OH.2010.28912] [Reference Citation Analysis]
5 Tarannum N, Kumar D, Surya SG, Dramou P. Point-of-care detection assay based on biomarker-imprinted polymer for different cancers: a state-of-the-art review. Polym Bull . [DOI: 10.1007/s00289-022-04085-6] [Reference Citation Analysis]
6 Shimofusa R, Ueda T, Kishimoto T, Nakajima M, Yoshikawa M, Kondo F, Ito H. Magnetic resonance imaging of hepatocellular carcinoma: a pictorial review of novel insights into pathophysiological features revealed by magnetic resonance imaging. Journal of Hepato-Biliary-Pancreatic Sciences 2010;17:583-9. [DOI: 10.1007/s00534-009-0198-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
7 Zhou F, Wei H, Ye X, Hu K, Wu G, Yang H, He Y, Xie S, Guo Z. Influence of nanoparticles accumulation on optical properties of human normal and cancerous liver tissue in vitro estimated by OCT. Phys Med Biol 2015;60:1385-97. [PMID: 25592483 DOI: 10.1088/0031-9155/60/3/1385] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
8 Shen B, Yan J, Wang S, Zhou F, Zhao Y, Hu R, Qu J, Liu L. Label-free whole-colony imaging and metabolic analysis of metastatic pancreatic cancer by an autoregulating flexible optical system. Theranostics 2020;10:1849-60. [PMID: 32042340 DOI: 10.7150/thno.40869] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
9 Ringe KI, Wacker F. Radiological diagnosis in cholangiocarcinoma: Application of computed tomography, magnetic resonance imaging, and positron emission tomography. Best Pract Res Clin Gastroenterol. 2015;29:253-265. [PMID: 25966426 DOI: 10.1016/j.bpg.2015.02.004] [Cited by in Crossref: 26] [Cited by in F6Publishing: 16] [Article Influence: 3.7] [Reference Citation Analysis]
10 Alaboudy A, Inoue T, Hatanaka K, Chung H, Hyodo T, Kumano S, Murakami T, Moustafa EF, Kudo M. Usefulness of combination of imaging modalities in the diagnosis of hepatocellular carcinoma using Sonazoid®-enhanced ultrasound, gadolinium diethylene-triamine-pentaacetic acid-enhanced magnetic resonance imaging, and contrast-enhanced computed tomography. Oncology. 2011;81 Suppl 1:66-72. [PMID: 22212939 DOI: 10.1159/000333264] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
11 Dai YW, Zhu LX, Zhang Y, Wang SH, Chen K, Jiang TT, Xu XL, Geng XP. Au@SiO2@CuInS2-ZnS/Anti-AFP fluorescent probe improves HCC cell labeling. Hepatobiliary Pancreat Dis Int 2019;18:266-72. [PMID: 30879890 DOI: 10.1016/j.hbpd.2019.03.001] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
12 Yang L, Marx H, Yen Y. Early finding of chest wall metastasis of hepatocellular carcinoma in a woman by fluorodeoxyglucose-positron emission tomography scan: a case report. J Med Case Rep 2011;5:147. [PMID: 21489297 DOI: 10.1186/1752-1947-5-147] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
13 Sadigh G, Applegate KE, Baumgarten DA. Comparative accuracy of intravenous contrast-enhanced CT versus noncontrast CT plus intravenous contrast-enhanced CT in the detection and characterization of patients with hypervascular liver metastases: a critically appraised topic. Acad Radiol 2014;21:113-25. [PMID: 24331274 DOI: 10.1016/j.acra.2013.08.023] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
14 Yu JI, Kim JS, Park HC, Lim DH, Han YY, Lim HC, Paik SW. Evaluation of anatomical landmark position differences between respiration-gated MRI and four-dimensional CT for radiation therapy in patients with hepatocellular carcinoma. Br J Radiol. 2013;86:20120221. [PMID: 23239694 DOI: 10.1259/bjr.20120221] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
15 Bieze M, Klümpen H, Verheij J, Beuers U, Phoa SS, van Gulik TM, Bennink RJ. Diagnostic accuracy of 18 F-methylcholine positron emission tomography/computed tomography for intra- and extrahepatic hepatocellular carcinoma. Hepatology 2014;59:996-1006. [DOI: 10.1002/hep.26781] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 3.8] [Reference Citation Analysis]
16 Mezale D, Strumfa I, Vanags A, Kalva A, Balodis D, Strumfs B, Fridrihsone I, Abolins A, Gardovskis J. Diagnostic Algorithm of Hepatocellular Carcinoma: Classics and Innovations in Radiology and Pathology. In: Teodor Streba C, Constantin Vere C, Rogoveanu I, editors. Hepatocellular Carcinoma - Advances in Diagnosis and Treatment. IntechOpen; 2018. [DOI: 10.5772/intechopen.76136] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
17 Cao H, Huang H, Xu W, Chen D, Yu J, Li J, Li L. Fecal metabolome profiling of liver cirrhosis and hepatocellular carcinoma patients by ultra performance liquid chromatography-mass spectrometry. Anal Chim Acta. 2011;691:68-75. [PMID: 21458633 DOI: 10.1016/j.aca.2011.02.038] [Cited by in Crossref: 74] [Cited by in F6Publishing: 70] [Article Influence: 6.7] [Reference Citation Analysis]
18 Song M, Park HJ, Lee ES, Ahn HS, Park SB. Value of precontrast and portal venous phases for evaluating atypical hepatocellular carcinoma mimicking arterioportal shunt. Eur J Radiol 2021;143:109933. [PMID: 34492626 DOI: 10.1016/j.ejrad.2021.109933] [Reference Citation Analysis]
19 Reitz S, Slam K, Chambers LW. Biliary, pancreatic, and hepatic imaging for the general surgeon. Surg Clin North Am. 2011;91:59-92. [PMID: 21184901 DOI: 10.1016/j.suc.2010.10.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
20 Ho J, Curley SA. Diagnosis and Management of Intrahepatic and Extrahepatic Cholangiocarcinoma. Cancer Treat Res 2016;168:121-63. [PMID: 29206368 DOI: 10.1007/978-3-319-34244-3_7] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
21 Rauchfuss F, Scheuerlein H, Götz M, Dittmar Y, Voigt R, Heise M, Settmacher U. [Hepatocellular carcinoma and cholangiocarcinoma]. Chirurg 2010;81:941-52; quiz 953. [PMID: 20827454 DOI: 10.1007/s00104-009-1864-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
22 Bellissimo F, Pinzone MR, Cacopardo B, Nunnari G. Diagnostic and therapeutic management of hepatocellular carcinoma. World J Gastroenterol 2015; 21(42): 12003-12021 [PMID: 26576088 DOI: 10.3748/wjg.v21.i42.12003] [Cited by in CrossRef: 43] [Cited by in F6Publishing: 41] [Article Influence: 6.1] [Reference Citation Analysis]
23 Huang SC, Liang JD, Hsu SJ, Hong TC, Yang HC, Kao JH. Direct comparison of biopsy techniques for hepatic malignancies. Clin Mol Hepatol 2021;27:305-12. [PMID: 33317239 DOI: 10.3350/cmh.2020.0301] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
24 Heidenreich A, Krege S. [Pharmacological therapy of urogenital cancer: rational routine diagnostic imaging]. Urologe A 2013;52:1564-73. [PMID: 24197084 DOI: 10.1007/s00120-013-3253-y] [Reference Citation Analysis]
25 Hu J, Tang J, Lin C, Chu Y, Liu N. Preoperative staging of cholangiocarcinoma and biliary carcinoma using 18F-fluorodeoxyglucose positron emission tomography: a meta-analysis. J Investig Med 2018;66:52-61. [DOI: 10.1136/jim-2017-000472] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
26 Zender L, Malek NP. [Diagnostics and treatment of cholangiocellular carcinoma]. Internist (Berl) 2016;57:1191-205. [PMID: 27822622 DOI: 10.1007/s00108-016-0128-5] [Reference Citation Analysis]
27 Chiang MF, Tseng TK, Shih CW, Yang TH, Wu SY. Clinical and contrast-enhanced image features in the prediction model for the detection of small hepatocellular carcinomas. J Cancer 2020;11:7166-75. [PMID: 33193879 DOI: 10.7150/jca.47245] [Reference Citation Analysis]
28 Choi BI, Lee JM. Advancement in HCC imaging: diagnosis, staging and treatment efficacy assessments: Imaging diagnosis and staging of hepatocellular carcinoma. Journal of Hepato-Biliary-Pancreatic Sciences 2010;17:369-73. [DOI: 10.1007/s00534-009-0227-y] [Cited by in Crossref: 39] [Cited by in F6Publishing: 29] [Article Influence: 3.0] [Reference Citation Analysis]
29 Grassi I, Morigi JJ, Nanni C, Fanti S. FDG and other radiopharmaceuticals in the evaluation of liver lesions. Clin Transl Imaging 2014;2:115-27. [DOI: 10.1007/s40336-014-0059-x] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
30 Yu JI, Park HC, Lim DH, Choi Y, Jung SH, Paik SW, Kim SH, Jeong WK, Kim YK. The role of diffusion-weighted magnetic resonance imaging in the treatment response evaluation of hepatocellular carcinoma patients treated with radiation therapy. Int J Radiat Oncol Biol Phys. 2014;89:814-821. [PMID: 24969795 DOI: 10.1016/j.ijrobp.2014.03.020] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
31 Horie S, Chen R, Li L, Mori S, Kodama T. Contrast-enhanced high-frequency ultrasound imaging of early stage liver metastasis in a preclinical mouse model. Cancer Lett. 2013;339:208-213. [PMID: 23791880 DOI: 10.1016/j.canlet.2013.06.006] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
32 Xu LH, Cai SJ, Cai GX, Peng WJ. Imaging diagnosis of colorectal liver metastases. World J Gastroenterol 2011; 17(42): 4654-4659 [PMID: 22180707 DOI: 10.3748/wjg.v17.i42.4654] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
33 Umar NK, Badshah MB, Sandrasegaran K, Ghabril M, Agarwal S, Tann M, Lacerda M, Kwo PY. The Presence of Portal Vein Thrombosis Alters the Classic Enhancement Associated with Diagnosis of Hepatocellular Carcinoma. Dig Dis Sci 2015;60:2196-200. [DOI: 10.1007/s10620-015-3587-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
34 Dhanasekaran R, Limaye A, Cabrera R. Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis, and therapeutics. Hepat Med. 2012;4:19-37. [PMID: 24367230 DOI: 10.2147/hmer.s16316] [Cited by in Crossref: 39] [Cited by in F6Publishing: 132] [Article Influence: 3.9] [Reference Citation Analysis]
35 Wadsworth CA, Lim A, Taylor-robinson SD, Khan SA. The risk factors and diagnosis of cholangiocarcinoma. Hepatol Int 2013;7:377-93. [DOI: 10.1007/s12072-012-9407-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
36 Marshall G, Sykes A, Berry J, Jonker L. The “humble” bubble: Contrast-enhanced ultrasound. Radiography 2011;17:345-9. [DOI: 10.1016/j.radi.2011.05.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
37 Wong GLH, Xu HX, Xie XY. Detection Of Focal Liver Lesions In Cirrhotic Liver Using Contrast-Enhanced Ultrasound. World J Radiol 2009; 1(1): 25-36 [PMID: 21160718 DOI: 10.4329/wjr.v1.i1.25] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
38 Li Z, Mao Y, Huang W, Li H, Zhu J, Li W, Li B. Texture-based classification of different single liver lesion based on SPAIR T2W MRI images. BMC Med Imaging. 2017;17:42. [PMID: 28705145 DOI: 10.1186/s12880-017-0212-x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 8.2] [Reference Citation Analysis]
39 Pan JH, Dong MJ, Ouyang XB. A hepatoid adenocarcinoma of the stomach with liver metastasis mimicking hepatocellular carcinoma detected by F-18 FDG PET/CT imaging. Clin Nucl Med. 2011;36:1137-1139. [PMID: 22064094 DOI: 10.1097/rlu.0b013e3182335ef9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
40 Kim HY, Choi JY, Kim CW, Bae SH, Yoon SK, Lee YJ, Rha SE, You YK, Kim DG, Jung ES. Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging predicts the histological grade of hepatocellular carcinoma only in patients with Child-Pugh class A cirrhosis. Liver Transpl 2012;18:850-7. [PMID: 22407909 DOI: 10.1002/lt.23426] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
41 Yang S, Ji Q, Chang B, Wang Y, Zhu Y, Li D, Huang C, Wang Y, Sun G, Zhang L, Guan Q, Xiang J, Wei W, Lu Z, Liao T, Meng J, Wang Z, Ma B, Zhou L, Wang Y, Yang G. STC2 promotes head and neck squamous cell carcinoma metastasis through modulating the PI3K/AKT/Snail signaling. Oncotarget. 2017;8:5976-5991. [PMID: 27863406 DOI: 10.18632/oncotarget.13355] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 7.3] [Reference Citation Analysis]
42 Guro H, Kim JW, Choi Y, Cho JY, Yoon YS, Han HS. Multidisciplinary management of intrahepatic cholangiocarcinoma: Current approaches. Surg Oncol 2017;26:146-52. [PMID: 28577720 DOI: 10.1016/j.suronc.2017.03.001] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 6.0] [Reference Citation Analysis]
43 Thai Doan K, Nguyễn Việt L, Nguyen Tien T, Nguyen Canh B, Ngo Thi H, Nguyen Thanh N, Bui Quang B, Le Van Q, Woong Lee H, Mai Hong B. Prognostic Factors of Radiofrequency Ablation plus Systemic Chemotherapy for Unresectable Colorectal Cancer with Liver Metastasis. Int J Hepatol 2020;2020:8836922. [PMID: 33381321 DOI: 10.1155/2020/8836922] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Li M, Yang Y, Kuang Y, Gan X, Zeng W, Liu Y, Guan H. miR-365 induces hepatocellular carcinoma cell apoptosis through targeting Bcl-2. Exp Ther Med. 2017;13:2279-2285. [PMID: 28565839 DOI: 10.3892/etm.2017.4244] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
45 Corona-villalobos CP, Kamel IR. Functional Volumetric MRI in Assessing Treatment Response to Intra-Arterial Therapy of Primary and Secondary Liver Tumors: . Journal of Computer Assisted Tomography 2014;38:513-7. [DOI: 10.1097/rct.0000000000000072] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
46 Shariff MI, Cox IJ, Gomaa AI, Khan SA, Gedroyc W, Taylor-robinson SD. Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics. Expert Review of Gastroenterology & Hepatology 2014;3:353-67. [DOI: 10.1586/egh.09.35] [Cited by in Crossref: 197] [Cited by in F6Publishing: 194] [Article Influence: 24.6] [Reference Citation Analysis]
47 Moritz T, Prosch H, Schuster H, Ba-Ssalamah A. [Malignant focal liver lesions]. Radiologe 2011;51:697-703. [PMID: 21847779 DOI: 10.1007/s00117-010-2128-0] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
48 Thomsen MK, Skouboe MK, Boularan C, Vernejoul F, Lioux T, Leknes SL, Berthelsen MF, Riedel M, Cai H, Joseph JV, Perouzel E, Tiraby M, Vendelbo MH, Paludan SR. The cGAS-STING pathway is a therapeutic target in a preclinical model of hepatocellular carcinoma. Oncogene 2020;39:1652-64. [PMID: 31740782 DOI: 10.1038/s41388-019-1108-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
49 Yoon H, Zhu YI, Yarmoska SK, Emelianov SY. Design and Demonstration of a Configurable Imaging Platform for Combined Laser, Ultrasound, and Elasticity Imaging. IEEE Trans Med Imaging 2019;38:1622-32. [PMID: 30596572 DOI: 10.1109/TMI.2018.2889736] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
50 Peng X, Lin G, Zeng Y, Lei Z, Liu G. Mesoporous Silica Nanoparticle-Based Imaging Agents for Hepatocellular Carcinoma Detection. Front Bioeng Biotechnol 2021;9:749381. [PMID: 34869261 DOI: 10.3389/fbioe.2021.749381] [Reference Citation Analysis]
51 Didié M, Zimmermann WH. Ultrasound techniques for the detection of tumors and metastases in small animals. Methods Mol Biol 2014;1070:181-90. [PMID: 24092440 DOI: 10.1007/978-1-4614-8244-4_13] [Reference Citation Analysis]
52 Li XH, Liang Q, Chen TW, Wang J, Zhang XM. Diagnostic value of imaging examinations in patients with primary hepatocellular carcinoma. World J Clin Cases 2018; 6(9): 242-248 [PMID: 30211204 DOI: 10.12998/wjcc.v6.i9.242] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
53 Oyama A, Hiraoka Y, Obayashi I, Saikawa Y, Furui S, Shiraishi K, Kumagai S, Hayashi T, Kotoku J. Hepatic tumor classification using texture and topology analysis of non-contrast-enhanced three-dimensional T1-weighted MR images with a radiomics approach. Sci Rep. 2019;9:8764. [PMID: 31217445 DOI: 10.1038/s41598-019-45283-z] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
54 Pilapong C, Raiputta C, Chaisupa J, Sittichai S, Thongtem S, Thongtem T. Magnetic-EpCAM nanoprobe as a new platform for efficient targeting, isolating and imaging hepatocellular carcinoma. RSC Adv 2015;5:30687-93. [DOI: 10.1039/c5ra01566a] [Cited by in Crossref: 6] [Article Influence: 0.9] [Reference Citation Analysis]
55 Burti S, Zotti A, Contiero B, Banzato T. Computed tomography features for differentiating malignant and benign focal liver lesions in dogs: A meta-analysis. Vet J 2021;278:105773. [PMID: 34742915 DOI: 10.1016/j.tvjl.2021.105773] [Reference Citation Analysis]
56 Patel M, Shariff MI, Ladep NG, Thillainayagam AV, Thomas HC, Khan SA, Taylor-Robinson SD. Hepatocellular carcinoma: diagnostics and screening. J Eval Clin Pract 2012;18:335-42. [PMID: 21114800 DOI: 10.1111/j.1365-2753.2010.01599.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 2.2] [Reference Citation Analysis]
57 Kim JU, Shariff MIF, Crossey MME, Gomez-Romero M, Holmes E, Cox IJ, Fye HKS, Njie R, Taylor-Robinson SD. Hepatocellular carcinoma: Review of disease and tumor biomarkers. World J Hepatol 2016; 8(10): 471-484 [PMID: 27057305 DOI: 10.4254/wjh.v8.i10.471] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 6.2] [Reference Citation Analysis]
58 Geng L, Lin C, Huang B, Long XA, Dai BH, Cong WM, Yang JM. Solitary necrotic nodule of the liver: MR findings in 33 pathologically proved lesions. Eur J Radiol 2012;81:623-9. [PMID: 21354738 DOI: 10.1016/j.ejrad.2011.01.079] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
59 Dimopoulos YP, Winslow ER, He AR, Ozdemirli M. Hepatocellular carcinoma with biliary and neuroendocrine differentiation: A case report. World J Clin Oncol 2021; 12(4): 262-271 [PMID: 33959479 DOI: 10.5306/wjco.v12.i4.262] [Reference Citation Analysis]